Turkiye Sinai Kalkinma Bankasi AS
OTC:TRKYY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Turkiye Sinai Kalkinma Bankasi AS
OTC:TRKYY
|
TR |
|
C
|
Chugai Pharmaceutical Co Ltd
SWB:CUP
|
JP |
|
F
|
Fisher & Paykel Healthcare Corporation Ltd
XBER:FPLB
|
NZ |
|
F
|
Fisher & Paykel Healthcare Corporation Ltd
ASX:FPH
|
NZ |
|
Fisher & Paykel Healthcare Corporation Ltd
F:FPLB
|
NZ |
Wall St Price Targets
TRKYY Price Targets Summary
Turkiye Sinai Kalkinma Bankasi AS
According to Wall Street analysts, the average 1-year price target for TRKYY is 3.06 USD with a low forecast of 2.69 USD and a high forecast of 3.68 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TRKYY's stock price target?
Price Target
3.06
USD
According to Wall Street analysts, the average 1-year price target for TRKYY is 3.06 USD with a low forecast of 2.69 USD and a high forecast of 3.68 USD.
What is the Revenue forecast for Turkiye Sinai Kalkinma Bankasi AS?
Projected CAGR
-9%
Over the last 13 years, the compound annual growth rate for Revenue has been 38%. The projected CAGR for the next 2 years is -9%.
What is the Net Income forecast for Turkiye Sinai Kalkinma Bankasi AS?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Net Income has been 32%. The projected CAGR for the next 2 years is 24%.
